Document is current
Any future updates will be listed below
-
Authors
Jamshidi, Javad
Rowntree, Conor
Fadaee, Shannon
Zhang, Futao
Zhu, Ying
Buckley, Michael
Hart, Franki
Roscioli, Tony
-
Funding
Funding for this research was provided by:
University of New South Wales Sydney and the Medical Research Futures Fund PreGen program (GHFMPACI000006)
University of New South Wales Sydney and the Medical Research Futures Fund PreGen program (GHFMPACI000006)
University of New South Wales Sydney and the Medical Research Futures Fund PreGen program (GHFMPACI000006)
- License Information
-
More Information
Article History
Received: 29 July 2025
Accepted: 6 October 2025
First Online: 19 November 2025
Declarations
:
: This project was reviewed by the South Eastern Sydney Local Health District Human Research Ethics Committee (HREC) at a meeting of its Low and Negligible Risk (LNR) Committee, which determined that the project did not involve any ethical risks and was exempt from full ethical review, in accordance with the NHMRC National Statement (updated 2023) —Sect. 5.1.22 , the NHMRC Ethical Considerations in Quality Assurance and Evaluation Activities (2014) guidance and NSW Health Guideline GL2007_020 Human Research Ethics Committees - Quality Improvement and Ethics Review: A Practice Guide for NSW . The study was conducted in accordance with the Declaration of Helsinki. This study does not include human participants and only publicly available, de-identified human genomic data (HG002 sample from the Genome in a Bottle Consortium) was used; no informed consent was required.
: Not applicable.
: The authors declare no competing interests.
